Valved Holding Chambers in Young Children With Acute Wheezing: A Randomized Clinical Trial - Report - MDSpire

Valved Holding Chambers in Young Children With Acute Wheezing: A Randomized Clinical Trial

  • By

  • Péter Csonka

  • Terhi Ruuska-Loewald

  • Inka Hämynen

  • Minna Honkila

  • Iida Ojaniemi

  • Eeva Mykkänen

  • Balázs Kelemen

  • Minna Juntunen

  • Salla Kuusela

  • Marjo Renko

  • Lauri Lehtimäki

  • Tytti Pokka

  • Sauli Palmu

  • May 1, 2026

  • 0 min

Share

Clinical Report: Efficacy of Valved Holding Chambers for Acute Wheezing in Pediatric Patients

Overview

This randomized clinical trial evaluates the efficacy of two commercially available valved holding chambers (VHCs) for delivering salbutamol in young children with acute wheezing. Results indicate significant differences in clinical outcomes based on the VHC used, highlighting the importance of device selection in pediatric respiratory care.

Background

Acute wheezing is a prevalent condition in pediatric emergency care, leading to substantial hospitalizations. The choice of inhalation device, particularly valved holding chambers, can significantly impact drug delivery and clinical outcomes. Understanding the efficacy of different VHCs is crucial for optimizing treatment in young children experiencing acute wheezing.

Data Highlights

VHC GroupDrug Delivery PerformanceClinical Response
VHC-1 (Optichamber Diamond)HighMore favorable
VHC-2 (Babyhaler)LowLess favorable

Key Findings

  • Acute wheezing accounts for 10% of pediatric emergency visits, with high hospitalization rates.
  • In vitro studies show up to 23-fold differences in drug delivery between VHCs.
  • The trial compared VHC-1 (high delivery) and VHC-2 (low delivery) in children aged 6 to 48 months.
  • Children receiving treatment via VHC-1 demonstrated a more favorable clinical response compared to VHC-2.
  • Randomized clinical trials evaluating VHC efficacy in pediatric patients are limited.

Clinical Implications

Healthcare providers should consider the specific VHC used for delivering salbutamol in young children with acute wheezing, as device selection can significantly affect treatment outcomes. This study underscores the need for further research to establish guidelines for VHC use in pediatric respiratory therapy.

Conclusion

The findings of this trial emphasize the critical role of valved holding chambers in the management of acute wheezing in children. Selecting the appropriate VHC can enhance clinical efficacy and improve patient outcomes.

References

  1. Valved Holding Chambers in Young Children With Acute Wheezing: A Randomized Clinical Trial | Trials | JAMA Pediatrics | JAMA Network, 2023 -- Title
  2. Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma - PMC, 2020 -- Title
  3. Guidelines for Mechanical Ventilation in Critically Ill Pediatric Patients from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC), Intensive Care Medicine, 2017 -- Title
  4. Intensive Care Medicine — Review of Key Developments in Intensive Care Medicine for 2009: Focus on Mechanical Ventilation, Acute Lung Injury, Respiratory Distress Syndrome, Pediatric Considerations, Ethical Issues, and Additional Topics
  5. Intensive Care Medicine — Highlights from Intensive Care Medicine 2012: Focus on Noninvasive Ventilation, Patient Monitoring, Ventilator Interactions, Acute Respiratory Distress Syndrome, Sedation Practices, Pediatric Considerations, and Additional Topics
  6. Intensive Care Medicine — Assessment of End-Expiratory Lung Volume in Intubated Pediatric Patients During Continuous Mechanical Ventilation
  7. GINA 2025 Global Strategy for Asthma Management and Prevention
  8. Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma - PMC
  9. Valved Holding Chambers in Young Children With Acute Wheezing: A Randomized Clinical Trial | Trials | JAMA Pediatrics | JAMA Network

Original Source(s)

Related Content